TCL Archive NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies October 18, 1974
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012